Clinical Trials
3
Active:1
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor
Phase 1
Completed
- Conditions
- Breast CancerNSCLCEndometrial CancerOvary CancerSmall Cell Lung Cancer (SCLC)Head and Neck (HNSCC)
- Interventions
- First Posted Date
- 2014-02-24
- Last Posted Date
- 2019-05-21
- Lead Sponsor
- Cristiana Sessa
- Target Recruit Count
- 17
- Registration Number
- NCT02069158
- Locations
- 🇨🇭
Oncology Institute of Southern Switzerland (IOSI), Bellinzona, TI, Switzerland
Study of Inotuzumab Ozogamicin + Temsirolimus in Patients With Relapsed or Refractory CD22+ B-cell NHLymphoma
Phase 1
Completed
- Conditions
- B-cell Lymphoma Refractory
- Interventions
- First Posted Date
- 2012-02-20
- Last Posted Date
- 2016-06-07
- Lead Sponsor
- Cristiana Sessa
- Target Recruit Count
- 25
- Registration Number
- NCT01535989
- Locations
- 🇨🇭
Oncology Institute of Southern Switzerland, Bellinzona, Ticino, Switzerland
🇨🇭InselSpital, Universitätsspital Bern, Bern, Switzerland
🇨🇭Kantonsspital St.Gallen, San Gallen, Switzerland
News
No news found